Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Henderson

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Reviews in Urology|May 5, 2018
The LUGPA Alternative Payment Model for Initial Therapy of Newly Diagnosed Patients With Organ-confined Prostate Cancer: Rationale and DevelopmentDeepak A Kapoor, Neal D Shore, Gary M Kirsh, et al.
The Journal of Urology|February 19, 2013
PCA3 molecular urine test as a predictor of repeat prostate biopsy outcome in men with previous negative biopsies: a prospective multicenter clinical studyMarc C Gittelman, Bernard Hertzman, James Bailen, et al.
Pediatric Emergency Care|May 29, 2025
A Descriptive Analysis of the Reliability of the Broselow Tape for Use in the US Pediatric Trauma Population: A Trauma Quality Improvement Program StudyIan S McCullough, Melissa L Givens, Kelli J Welter, et al.
The Journal of Urology|October 8, 2013
Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasiaAdolfo Casabé, Claus G Roehrborn, Luigi F Da Pozzo, et al.
Urology|April 30, 2017
Use of a 17-Gene Prognostic Assay in Contemporary Urologic Practice: Results of an Interim Analysis in an Observational CohortGregg Eure, Raymond Germany, Robert Given, et al.
The Prostate|March 5, 2020
Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelinesNeal D Shore, Emmanuel S Antonarakis, Michael S Cookson, et al.
The Canadian Journal of Urology|October 13, 2020
Evolving understanding and categorization of prostate cancer: preventing progression to metastatic castration-resistant prostate cancer: RADAR IVE David Crawford, Gerald Andriole, Stephen J Freedland, et al.
Urologic Oncology|April 20, 2020
Development and evaluation of the MiCheck test for aggressive prostate cancerNeal D Shore, Christopher M Pieczonka, R Jonathan Henderson, et al.
Urologic Oncology|May 4, 2020
A comparison of prostate health index, total PSA, %free PSA, and proPSA in a contemporary US population-The MiCheck-01 prospective trialNeal D Shore, Christopher M Pieczonka, R Jonathan Henderson, et al.
The Journal of Urology|October 4, 2019
The Impact of Late Luteinizing Hormone-Releasing Hormone Agonist Dosing on Testosterone Suppression in Patients with Prostate Cancer: An Analysis of United States Clinical DataE David Crawford, Przemyslaw W Twardowski, Raoul S Concepcion, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Reviews in Urology|May 5, 2018
The LUGPA Alternative Payment Model for Initial Therapy of Newly Diagnosed Patients With Organ-confined Prostate Cancer: Rationale and DevelopmentDeepak A Kapoor, Neal D Shore, Gary M Kirsh, et al.
The Journal of Urology|February 19, 2013
PCA3 molecular urine test as a predictor of repeat prostate biopsy outcome in men with previous negative biopsies: a prospective multicenter clinical studyMarc C Gittelman, Bernard Hertzman, James Bailen, et al.
Pediatric Emergency Care|May 29, 2025
A Descriptive Analysis of the Reliability of the Broselow Tape for Use in the US Pediatric Trauma Population: A Trauma Quality Improvement Program StudyIan S McCullough, Melissa L Givens, Kelli J Welter, et al.
The Journal of Urology|October 8, 2013
Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasiaAdolfo Casabé, Claus G Roehrborn, Luigi F Da Pozzo, et al.
Urology|April 30, 2017
Use of a 17-Gene Prognostic Assay in Contemporary Urologic Practice: Results of an Interim Analysis in an Observational CohortGregg Eure, Raymond Germany, Robert Given, et al.
The Prostate|March 5, 2020
Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelinesNeal D Shore, Emmanuel S Antonarakis, Michael S Cookson, et al.
The Canadian Journal of Urology|October 13, 2020
Evolving understanding and categorization of prostate cancer: preventing progression to metastatic castration-resistant prostate cancer: RADAR IVE David Crawford, Gerald Andriole, Stephen J Freedland, et al.
Urologic Oncology|April 20, 2020
Development and evaluation of the MiCheck test for aggressive prostate cancerNeal D Shore, Christopher M Pieczonka, R Jonathan Henderson, et al.
Urologic Oncology|May 4, 2020
A comparison of prostate health index, total PSA, %free PSA, and proPSA in a contemporary US population-The MiCheck-01 prospective trialNeal D Shore, Christopher M Pieczonka, R Jonathan Henderson, et al.
The Journal of Urology|October 4, 2019
The Impact of Late Luteinizing Hormone-Releasing Hormone Agonist Dosing on Testosterone Suppression in Patients with Prostate Cancer: An Analysis of United States Clinical DataE David Crawford, Przemyslaw W Twardowski, Raoul S Concepcion, et al.
Pageof 3